Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group George FountzilasDimitrios PectasidesHelen Gogas Report Pages: 1 - 9
Soyfood intake and breast cancer survival: a followup of the Shanghai Breast Cancer Study Sonia M. BoyapatiXiao-ou ShuWei Zheng Report Pages: 11 - 17
The impact of a second breast cancer diagnosis on health related quality of life Andrea A. ThorntonLisa Madlenskyfor the Women’s Healthy Eating and Living (WHEL) Study Group Report Pages: 25 - 33
Breast self-examination practices among women from six ethnic groups and the influence of cancer worry Elizabeth Kudadjie-GyamfiNathan ConsedineJessy Pierre-Louis Report Pages: 35 - 45
Long-term dysregulation of circadian and 17-β estradiol-induced LH, prolactinand corticosterone secretion after dimethylbenz (a) anthracene administrationin the Sprague–Dawley female rat M. Beau Yon De Jonage-CanonicoV. LenoirB. Kerdelhué Report Pages: 47 - 50
Extracorporeal high intensity focused ultrasound treatment for patients with breast cancer Feng WuZhi-Biao WangHai-Bing Su OriginalPaper Pages: 51 - 60
Radiological and surgical placement of port devices: a 4-year institutional analysis of procedure performance, quality of life and cost in breast cancer patients P. -Y. MarcyN. MagnéJ. -C. Gallard Report Pages: 61 - 67
Predictive value of apoptosis, proliferation, HER-2, and topoisomerase IIα for anthracycline chemotherapy in locally advanced breast cancer G. ArpinoD. R. CioccaS. K. Mohsin Clinical trial Pages: 69 - 75
The S-phase fraction of the aneuploid cell subpopulation is the biologically relevant one in aneuploid breast cancers F. Martinez-ArribasM. J. Nuñez-VillarJ. Schneider Brief Communication Pages: 77 - 80
No adverse effects of adjuvant chemotherapy on hippocampal volumein Japanese breast cancer survivors Eisho YoshikawaYutaka MatsuokaYosuke Uchitomi Brief Communication Pages: 81 - 84
Evaluation of the CD107 cytotoxicity assay for the detection of cytolytic CD8+ cells recognizing HER2/neu vaccine peptides Elizabeth A. MittendorfCatherine E. StorrerGeorge E. Peoples Brief Communication Pages: 85 - 93
Lamivudine therapy in HBsAg-carrying breast cancer patients undergoing chemotherapy: prophylactic or preemptive? Ming-Shen DaiTsu-Yi Chao Letter to the editor Pages: 95 - 96